The US drug regulator on Wednesday granted emergency use authorization to German health technology company Siemens Healthineers' at-home COVID-19 tests, Reuters reports.
The test, which is expected to be available starting January, can be used for self-testing in people as young as 14 or adult-collected samples from individuals aged 2 to 13 years, Siemens said.
Read more